Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspire-Lakewood Holdings, Inc.PWUP · Entity 7885 | Chief Financial Officer | August 18, 2023 | August 26, 2023 |
| DataMeds AI, Inc.WGRX · Entity 8434 | Director | October 02, 2025 | October 24, 2025 |
| Kernel Group Holdings, Inc.KRNL · Entity 111780 | Chief Financial Officer | December 28, 2022 | March 28, 2023 |
| Ocean Biomedical, Inc.AEHA · Entity 8695 | Chief Financial Officer | September 14, 2021 | September 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspire-Lakewood Holdings, Inc.
Report date August 18, 2023 · Filed August 26, 2023
This filing explicitly reported no securities owned.
DataMeds AI, Inc.
Report date October 02, 2025 · Filed October 24, 2025
This filing explicitly reported no securities owned.
Kernel Group Holdings, Inc.
Report date December 28, 2022 · Filed March 28, 2023
This filing explicitly reported no securities owned.
Ocean Biomedical, Inc.
Report date September 14, 2021 · Filed September 20, 2021
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Scienture Holdings, Inc.
Report date April 02, 2022 · Filed April 04, 2022
Section 16 reporting ended · disclosed 2022-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 12,500 |
Reported balance
Holding disclosure · report date 2022-04-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 12,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2020 Filed Apr 15, 2020 23:58 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 12,500 | $6.12 | $76,500.00 |
DisclosureSEC source: 0001493152-20-006497 · ownership.xml · nonDerivative · entry 1 Doss Howard A. · CIK 0001616534 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2020 and January 1 and April 1, 2021, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Financial Officer. Read SEC document |
| May 13, 2019 Filed May 14, 2019 19:54 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001078782-19-000431 · primary_doc.xml · derivative · entry 1 Doss Howard A. · CIK 0001616534 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,281 Underlying: Common Stock · 20,000 shares Expires 2019-05-13 F1 · derivative.exercise_date: Option vests and becomes exercisable quarterly over four years. Read SEC document |
| April 26, 2018 Filed Apr 30, 2018 22:11 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Options · Derivative | 37,500 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001078782-18-000492 · primary_doc.xml · derivative · entry 1 Doss Howard A. · CIK 0001616534 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,500 Underlying: Common Stock · 37,500 shares Expires 2028-04-01 F1 · derivative.exercise_date: Option vests and becomes exercisable quarterly over four years. Read SEC document |
| April 01, 2016 Filed Feb 14, 2018 23:19 UTC | Scienture Holdings, Inc. TRXD · Entity 7802 | GrantStock Option · Derivative | 15,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001078782-18-000171 · primary_doc.xml · derivative · entry 1 Doss Howard A. · CIK 0001616534 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-04-01 F1 · derivative.exercise_date: Options vest quarterly over four years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.